Shanghai RAAS Blood Products Co., Ltd.
002252
Classement en actions
#3568
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Prix de l'action
$0.72625991
Capitalisation boursière
$4.79B
Changement (1 jour)
2.70%
Changement (1 an)
-22.68%
Pays
CN
Échange Shanghai RAAS Blood Products Co., Ltd. (002252)
Catégorie
Healthcare
Ratio P/B pour Shanghai RAAS Blood Products Co., Ltd. (002252)
Ratio P/B au October 2026 TTM : 1.01
Selon les derniers rapports financiers et le cours de l'action de Shanghai RAAS Blood Products Co., Ltd., le ratio cours/valeur comptable actuel (TTM) est 1.01. À la fin de 2023, le ratio P/B était de 1.70.
Historique du ratio P/B pour Shanghai RAAS Blood Products Co., Ltd. de 2005 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| 2026 (TTM) | 1.01 | -32.79% |
| 2024 | 1.50 | -11.55% |
| 2023 | 1.70 | 14.59% |
| 2022 | 1.48 | -16.45% |
| 2021 | 1.77 | -10.61% |
| 2020 | 1.99 | -39.37% |
| 2019 | 3.27 | -8.41% |
| 2018 | 3.58 | -54.12% |
| 2017 | 7.79 | -19.17% |
| 2016 | 9.64 | -6.16% |
| 2015 | 10.27 | 68.88% |
| 2014 | 6.08 | -86.55% |
| 2013 | 45.24 | 241.08% |
| 2012 | 13.26 | -5.97% |
| 2011 | 14.11 | -38.54% |
| 2010 | 22.95 | 46.93% |
| 2009 | 15.62 | 66.48% |
| 2008 | 9.38 | -68.34% |
| 2007 | 29.64 | 158.32% |
| 2006 | 11.47 | 47.63% |
| 2005 | 7.77 | 0.00% |
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| 6.251 | 520.02% |
US
|
|
| 13.2547 | 1,214.69% |
US
|
|
| 4.208 | 317.38% |
AU
|
|
| 6.1824 | 513.21% |
NL
|
|
| - | - |
CH
|
